Blog

Olubukola Ayodele: Why start breast cancer screening at 40?

Olubukola Ayodele/LinkedIn

Feb 24, 2025, 08:55

Olubukola Ayodele: Why start breast cancer screening at 40?

Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, shared a post on LinkedIn:

“Last December, I took a strong stand and signed a petition urging the UK government to establish a policy that funds breast cancer screening starting at age 40 and expand alternative screening options.

This petition also calls for the Government to actively promote and support the million women who missed their screening invitations in 2021/22, to remind those turning 50 of their eligibility, to re-engage individuals who have overlooked past invites, and to champion regular self-checks for early detection in mainstream media.

As a global oncology advocate, breast oncologist, and researcher, I have witnessed the profound consequences of delayed breast cancer detection on individuals and their families. The UK’s current routine screening policy beginning at age 50 neglects vital years when early detection can save lives. The Forrest report dates back to 1985! It’s time for a bold, patient-centered approach.

Why Start at 40?

Earlier Detection, Better Outcomes: With data showing that 1 in 6 breast cancers occur in women in their 40s, early detection translates to less aggressive treatment and improved survival rates. The rise in breast cancer incidence among younger women demands our attention.
Equity in Care: Many countries, including the U.S., Canada, Australia, and parts of Europe, have lowered their screening age guidelines. The UK must embrace global best practices and not be left behind.
Addressing Health Disparities: Women from Black, South Asian, and underserved communities often face more aggressive cancers at younger ages. Early screening can help bridge this critical gap.

Beyond Mammograms: The Need for Alternative Screening

While mammograms are invaluable, they are not universally applicable. Women with dense breasts or higher risk profiles may greatly benefit from ultrasound, MRI, or contrast-enhanced mammography, enhancing detection sensitivity. AI-powered imaging and risk-based screening models should be integrated.

A truly equitable approach to screening must provide access to personalized, risk-based strategies because early detection should never be limited by a one-size-fits-all model.

Kindly join this movement by signing the petition. We currently stand at 3,600 votes, but the aim is for 100,000 votes.

Repost this to spread the word!

Let us be the voice for the voiceless!

Lives depend on it. The science is clear. The need is urgent.

Will the UK government rise to the occasion?”

More posts featuring Olubukola Ayodele.